Stockreport

Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF - Total Revenues of $539.5 million, Cabozantinib Franchise U.S. Net Product Revenues of $478.1 million -- GAAP Diluted EPS of $0.40, Non-GAAP Diluted EPS of $0.47 -- Inc [Read more]